Mechanistic insights into dissolution of highly drug-loaded amorphous solid dispersions of a fast-crystallising drug

The dissolution behaviour of fast-crystallizing amorphous solid dispersions (ASDs) at drug loadings (DLs) far exceeding the amorphous solubility limit remains poorly understood. In this study, we investigate how extreme DLs influence dissolution mechanisms in naproxen-copovidone VA64 ASDs prepared by hot-melt extrusion at 20, 50, and 70 wt% DL. Rapid post-extrusion cooling was applied at 70% DL to kinetically suppress crystal growth, while lower DL formulations remained amorphous as confirmed by DSC and PXRD. Drug-polymer interactions were analysed using ATR-FTIR combined with principal component analysis. Saturation solubility measurements revealed moderate advantages of ASDs over physical mixtures, suggesting that polymer-mediated interfacial effects contribute to solubility enhancement independently of amorphization. Non-sink dissolution testing revealed a non-monotonic, DL-dependent behaviour. At 20% DL, naproxen remained amorphous for at least 2 h, enabling near-congruent drug-polymer release and the highest dissolution performance. At 50% DL, rapid surface crystallization within a dense swollen polymer layer restricted drug release. Unexpectedly, dissolution performance partially recovered at 70% DL despite crystallization, as the reduced polymer fraction generated a more porous hydrated layer that facilitated liquid penetration and drug release compared with 50% DL ASDs and physical mixtures. Spectroscopic analysis showed progressive loss of hydrogen bonding at intermediate and high DLs, while transient non-specific drug-polymer associations persisted and likely contributed to improved wettability. These findings demonstrate that dissolution enhancement in fast-crystallizing ASDs can be sustained above the amorphous solubility limit when the architecture of the hydrated layer - together with persistent non-specific drug-polymer interactions in aqueous media - governs drug transport rather than amorphous stability alone.

Authors

Institutions

Publication Details

Journal
European Journal of Pharmaceutics and Biopharmaceutics
Published
2026-04-30
DOI
https://doi.org/10.1016/j.ejpb.2026.115079
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mechanistic insights into dissolution of highly drug-loaded amorphous solid dispersions of a fast-crystallising drug

Valentyn Mohylyuk, Tetiana Kolisnyk
European Journal of Pharmaceutics and Biopharmaceutics
Drug Solubulity and Delivery Systems
article

Mechanistic insights into dissolution of highly drug-loaded amorphous solid dispersions of a fast-crystallising drug

Valentyn Mohylyuk, Tetiana Kolisnyk
article en

Abstract

The dissolution behaviour of fast-crystallizing amorphous solid dispersions (ASDs) at drug loadings (DLs) far exceeding the amorphous solubility limit remains poorly understood. In this study, we investigate how extreme DLs influence dissolution mechanisms in naproxen-copovidone VA64 ASDs prepared by hot-melt extrusion at 20, 50, and 70 wt% DL. Rapid post-extrusion cooling was applied at 70% DL to kinetically suppress crystal growth, while lower DL formulations remained amorphous as confirmed by DSC and PXRD. Drug-polymer interactions were analysed using ATR-FTIR combined with principal component analysis. Saturation solubility measurements revealed moderate advantages of ASDs over physical mixtures, suggesting that polymer-mediated interfacial effects contribute to solubility enhancement independently of amorphization. Non-sink dissolution testing revealed a non-monotonic, DL-dependent behaviour. At 20% DL, naproxen remained amorphous for at least 2 h, enabling near-congruent drug-polymer release and the highest dissolution performance. At 50% DL, rapid surface crystallization within a dense swollen polymer layer restricted drug release. Unexpectedly, dissolution performance partially recovered at 70% DL despite crystallization, as the reduced polymer fraction generated a more porous hydrated layer that facilitated liquid penetration and drug release compared with 50% DL ASDs and physical mixtures. Spectroscopic analysis showed progressive loss of hydrogen bonding at intermediate and high DLs, while transient non-specific drug-polymer associations persisted and likely contributed to improved wettability. These findings demonstrate that dissolution enhancement in fast-crystallizing ASDs can be sustained above the amorphous solubility limit when the architecture of the hydrated layer - together with persistent non-specific drug-polymer interactions in aqueous media - governs drug transport rather than amorphous stability alone.

European Journal of Pharmaceutics and BiopharmaceuticsVol. 224
Queen's University Belfast (GB), Riga Stradiņš University (LV)
British Academy
Openalex Percentile: Top 14%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.